Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2010

View Archived Issues

Alnylam provides key goals for next 18 months

Pharmasset provides new data on HCV candidate PSI-7851

ERalphaS118-P a potential biomarker for breast cancer response to tamoxifen

Novo Nordisk commences phase I trial with long-acting oral GLP-1 analogue

Sciele Pharma changes company name to Shionogi Pharma

Isis adds new drug to treat hypertriglyceridemia to development pipeline

Amicus Therapeutics presents development progress with Amigal

InterMune provides update on 2010 development program for RG-7227

Sorrento enters antibody alliance for MRSA infections

Idenix reports updated information on three of its HCV programs

AnaptysBio and Roche sign agreement for development of novel antibody therapeutics

Pharmaxis acquires Topigen

Shionogi receives marketing approval for peramivir in Japan

Genaera to sell remaining proprietary assets

Spectrum completes enrollment in second phase III pivotal apaziquone trial

Eisai submits application for approval of additional indication of Tambocor in Japan

Genfit reports results from phase I safety study of GFT-505/simvastatin combination

siRNA-nanosome formulations inhibit HCV RNA replication in interferon-resistant replicon cells

Activated protein C analogues slow progression in ALS model

Top2alpha proteasomal degradation can be inhibited to enhance cancer treatment

Novel sulfonylureas in development for diabetes therapy at Concert Pharmaceuticals

Bristol-Myers Squibb presents novel hepatitis C virus inhibitors

Yakult Honsha discovers novel Plk-1 inhibitors as oncolytics

Novel peptides for the diagnosis of invasive brain cancer described by U.S. scientists

Actelion Pharmaceuticals discloses novel antibacterials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...